Kawasaki Syndrome Completed Phase 3 Trials for Human immunoglobulin G (DB00028)

Also known as: Kawasaki syndrome / Mucocutaneous lymph node syndrome [Kawasaki] / Kawasaki's disease / Acute febrile mucocutaneous lymph node syndrome (MCLS) / Mucocutaneous Lymph Node Syndrome

IndicationStatusPhase
DBCOND0032078 (Kawasaki Syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00157079Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersTreatment